Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 06.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ge Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce |
| 09.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 10.1 and is incorporated herein by reference. Item 5.02. Departure of Directors or Certain Officers; Election of Directo |
| 28.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | tion 13(a) of the Exchange Act. o Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appoint |
| 16.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. o Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointme |
Stammdaten
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Unternehmen & Branche
| Name | Apyx Medical Corp |
|---|---|
| Ticker | APYX |
| CIK | 0000719135 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 145,6 Mio. USD |
| Beta | 1,54 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 52,844,000 | -11,211,000 | 66,840,000 | 14,540,000 | |
| 2025-09-30 | 10-Q | 12,877,000 | -1,984,000 | 57,365,000 | 5,848,000 | |
| 2025-06-30 | 10-Q | 11,373,000 | -3,778,000 | 58,188,000 | 7,253,000 | |
| 2025-03-31 | 10-Q | 9,430,000 | -4,150,000 | 60,160,000 | 10,511,000 | |
| 2024-12-31 | 10-K | 48,102,000 | -23,463,000 | 64,842,000 | 14,210,000 | |
| 2024-09-30 | 10-Q | 11,487,000 | -4,703,000 | 60,721,000 | 11,041,000 | |
| 2024-06-30 | 10-Q | 12,149,000 | -6,556,000 | -0.19 | 65,394,000 | 14,747,000 |
| 2024-03-31 | 10-Q | 10,244,000 | -7,576,000 | -0.22 | 70,711,000 | 20,253,000 |
| 2023-12-31 | 10-K | 52,349,000 | -18,713,000 | -0.54 | 79,240,000 | 26,701,000 |
| 2023-09-30 | 10-Q | 11,976,000 | -4,629,000 | -0.13 | 59,446,000 | 33,348,000 |
| 2023-06-30 | 10-Q | 13,569,000 | -994,000 | -0.03 | 62,429,000 | 36,596,000 |
| 2023-03-31 | 10-Q | 12,142,000 | -3,483,000 | -0.10 | 56,784,000 | 36,052,000 |
| 2022-12-31 | 10-K | 44,510,000 | -23,184,000 | -0.67 | 51,775,000 | 37,582,000 |
| 2022-09-30 | 10-Q | 9,114,000 | -5,764,000 | -0.17 | 55,268,000 | 41,990,000 |
| 2022-06-30 | 10-Q | 10,292,000 | -5,426,000 | -0.16 | 59,471,000 | 45,905,000 |
| 2022-03-31 | 10-Q | 12,493,000 | -5,945,000 | -0.17 | 62,997,000 | 49,561,000 |
| 2021-12-31 | 10-K | 48,517,000 | -15,172,000 | -0.44 | 68,721,000 | 53,704,000 |
| 2021-09-30 | 10-Q | 11,831,000 | -4,222,000 | -0.12 | 67,769,000 | 54,348,000 |
| 2021-06-30 | 10-Q | 11,224,000 | -4,046,000 | -0.12 | 69,597,000 | 57,358,000 |
| 2021-03-31 | 10-Q | 8,638,000 | -4,901,000 | -0.14 | 71,096,000 | 60,035,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.